NCT00186329View on ClinicalTrials.gov

BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

October 31, 2006

Conditions
Congestive Heart Failure ExacerbationRenal Insufficiency
Interventions
DRUG

Natrecor, a recombinant form of B-type Natriuretic Peptide, made by Scios, Inc. vs. placebo

Trial Locations (1)

94305

Stanford University Medical Center, Stanford

All Listed Sponsors
collaborator

Scios, Inc.

INDUSTRY

lead

Stanford University

OTHER

NCT00186329 - BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS) | Biotech Hunter | Biotech Hunter